Equity
-€9,925
Debts exceed assets in financial year 2025.
TANDENSS
Lifetime
3 annual accounts with figures on one time axispeak €42,095 (2025)
€42,095▲ 91.8%
lowest -€9,521 (2024)
-€930▲ €8,591
peak €526 (2023)
-€9,925▼ €930
€263,887▼ 13.1%
Board1 name since 2022
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Gross margin from €21,945 to €42,095Loss of €930Cash from €20,636 to €11,822
Key points
from the 2025 annual accountsLosses
-€13,925 in three years
Every financial year from 2023 to 2025 closed with a loss. 2024 was the heaviest.
Turnover
≈ €130,000 estimated
The micro format states no turnover.
Debts
€263,887 104% of the balance sheet
Financial debts 36%Suppliers 1%Taxes and wages 0%Other 63%
Of this, €169,817 falls due within a year.
Filings
3 annual accounts 1 late
The 2023 accounts came 29 days late. The other two were filed on time.
Position in the sector
-3.9%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 20,767 companies.
Checked score
53
Fair
Financially stronger than 11% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
Negative equity caps the score at 59.
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025lowest value
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.2%▲ +0.1 percentage points vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026highest value
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Capped at 59: negative equity
Negative equity -€9,925
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €253,962
Figures for financial year 2025 (filed on 29-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 3% of them on solvency, 3% on liquidity, 13% on profitability and 26% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 1,555 companies had the same profile as TANDENSS has now. Each dot stands for 4 companies, two years later.
91.6%
were still trading
3.6%
stopped another way
4.6%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of TANDENSS itself is lower: 0.2% within 12 months. It rests on far more data about TANDENSS than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,555 companies, not a prediction for TANDENSS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is insufficient, with a current ratio of 0.1 (0.12 in 2024), below 1. Short-term debt is 66.9% and cash 4.7% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
232425
2023 to 2025 · latest year -€9,925
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
32 days early
2024
31 days early
2023
29 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 11 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (3 of the last 3 accounts filed within 61 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- SOETAERT Stéphane Ghislain Lucien Jacques 1,000 sharesdeed of 21-12-2022
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0794961421
New establishment in Sint-Pieters-Leeuw
Stationsstraat 57
Incorporation
Founding capital of €4,000, 1,000 shares · Founder: SOETAERT Stéphane Ghislain Lucien Jacques · Appointment: SOETAERT Stéphane Ghislain Lucien Jacques (director) · published on 21-12-2022 · Gazette deed
First establishment
Drie Bomenstraat 48, Uccle
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| TANDENSS Uccle | €253,962 | €42,095 | -3.9% | - |
| RENOVDENTRISTE Auderghem | €181,877 | €42,466 | 96.1% | - |
| ND Malle | €220,320 | €45,594 | 98.6% | - |
| Tandartspraktijk Corpas Leuven | €250,034 | €53,740 | 54.4% | - |
| Tandarts An Baele Ghent | €299,878 | €55,378 | 27.1% | - |
| TANDARTS CATHARINA VLEMINCKX Zemst | €281,174 | €57,329 | 92.5% | - |
| Nejma Global Dentistry Anderlecht | €165,759 | €41,224 | 84.0% | - |
These companies have the same main activity as TANDENSS: dental practice (NACE 86230). They are comparable in size and age: total assets between €166,000 and €300,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 19-12-2022Normal situation
- Activity
- Dental practiceNACE 86230
- Establishment units
- 2.339.673.3551180 Uccle, since 19-12-2022
- 2.342.574.2491601 Sint-Pieters-Leeuw, since 21-12-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Annual accounts 2025
- €253,962▼ 13.8%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on TANDENSS
TANDENSS files the micro format. That format states no turnover. The gross margin rose from €19,886 in 2023 to €42,095 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about TANDENSS
- What is the company number of TANDENSS?
- The company number of TANDENSS is 0794.961.421. The VAT number is the same number with BE in front: BE 0794.961.421.
- Where is TANDENSS based?
- The registered office is at Drie Bomenstraat 48, 1180 Uccle.Company details
- What does TANDENSS do?
- According to the KBO register, the main activity is dental practice (NACE 86230).
- What is the legal form of TANDENSS?
- TANDENSS is a private limited company (BV).
- When was TANDENSS founded?
- TANDENSS was founded on 19-12-2022.
- Is TANDENSS still active?
- Yes, TANDENSS is an active enterprise in the KBO register.
- What is the turnover of TANDENSS?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €42,095 and 47 comparable companies (NACE 86). It probably lies between €93,000 and €180,000.Financials
- Is TANDENSS profitable?
- In financial year 2025, TANDENSS made a loss of €930.
- Where can I find the annual accounts of TANDENSS?
- TANDENSS filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of TANDENSS due?
- TANDENSS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.